CD95 ligand-dependant endothelial cell death initiates oral mucosa damage in a murine model of acute graft versus host disease

Laboratory Investigation

Volumn 87, Issue 5, 2007, Pages 417-429

  Deschaumes, Christophe ^a,b   Verneuil, Laurence ^a,b   Ertault Daneshpouy, Marjan ^b   Adle Biassette, Homa ^c   Galateau, Françoise ^d   Aïnoun, Fadela ^a   Micic Polianski, Juliette ^a   Janin, Anne ^b   Ameisen, Jean C ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM   (France)

^c BICHAT HOSPITAL   (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Apoptosis; CD95 ligand; Cell death; Endothelial cells; Graft versus host disease; Oral mucosa

Indexed keywords

FAS LIGAND;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL INJURY; CAPILLARY; CELL DEATH; CONTROLLED STUDY; ENDOTHELIUM CELL; KERATINOCYTE; LYMPHOCYTE; MOUSE; NONHUMAN; ORAL MUCOSAL DISEASE; PRIORITY JOURNAL; RECIPIENT;

EID: 34247367638     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700541     Document Type: Article

References (56)

1. Mitsuyasu RT, Champlin RE, Gale RP, et al. Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial. Ann Intern Med 1986;105:20-26.
2. Atkinson K, Biggs J, Cooley M, et al. A comparative study of T-cell depleted and non-depleted marrow transplantation for hematological malignancy. Aust NZ J Med 1987;17:16-23.
3. Baker MB, Riley RL, Podack ER, et al. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 1996;183:2645-2656.
4. Van den Brink MR, Burakoff SJ. Cytolytic pathways in haematopoietic stem-cell transplantation. Nat Rev Immunol 2002;2:273-281.
5. Barrett AP. Oral complications of bone marrow transplantation. Aust NZ J Med 1986;16:239-240.
6. Barrett AP, Bilous AM. Oral patterns of acute and chronic graft-v-host disease. Arch Dermatol 1984;120:1461-1465.
7. Carl W, Higby DJ. Oral manifestations of bone marrow transplantation. Am J Clin Oncol 1985;8:81-87.
8. Kolbinson DA, Schubert MM, Flournoy N, et al. Early oral changes following bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1988;66:130-138.
9. Seto BG, Kim M, Wolinsky L, et al. Oral mucositis in patients undergoing bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1985;60:493-497.
10. Schubert MM, Sullivan KM. Recognition, incidence, and management of oral graft-versus-host disease. NCI Monogr 1990;9:135-143.
11. Sale GE, Shulman HM, Schubert MM, et al. Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol 1981;12:1022-1030.
12. Sale GE, Gallucci BB, Schubert MM, et al. Direct ultrastructural evidence of target-directed polarization by cytotoxic lymphocytes in lesions of human graft-vs-host disease. Arch Pathol Lab Med 1987;111:333-336.
13. Sale GE, Raff RF, Storb R. Stem cell regions in filiform papillae of tongue as targets of graft-versus-host disease. Transplantation 1994; 58:1273-1275.
14. Lishner M, Patterson B, Kandel R, et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer 1990;65: 473-476.
15. Otsubo H, Yokoe H, Miya T, et al. Gingival squamous cell carcinoma in a patient with chronic graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:171-174.
16. Piguet PF, Grau GE, Allet B, et al. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J Exp Med 1987;166:1280-1289.
17. Braun MY, Lowin B, French L, et al. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996;183:657-661.
18. Via CS, Nguyen P, Shustov A, et al. A major role for the Fas pathway in acute graft-versus-host disease. J Immunol 1996;157:5387-5393.
19. Hattori K, Hirano T, Miyajima H, et al. Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies. Blood 1998;91:4051-4055.
20. Tsukada N, Kobata T, Aizawa Y, et al. Graft-versus leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation. Blood 1999;93:2738-2747.
21. Schmaltz C, Alpdogan O, Horndasch KJ, et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graftversus-host disease and graft-versus-leukemia effect. Blood 2001;97(9):2886-2895.
22. Janin A, Deschaumes C, Daneshpouy M, et al. CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. Blood 2002;99:2940-2947.
23. Graubert TA, Russell JH, Ley TJ. The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 1996;87:1232-1237.
24. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998;34:39-43.
25. Xun CQ, Thompson JS, Jennings CD, et al. Effect of total irradiation, busulfan-cyclophosphamide or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2 incompatible transplanted SCID mice. Blood 1994;83:2360-2367.
26. Korngold R, Sprent J. Surface markers of T cells causing lethal graft-vshost disease to class I vs class II H-2 differences. J Immunol 1985;135:3004-3010.
27. Korngold R, Sprent J. T cell subsets and graft-versus-host disease. Transplantation 1987;44:335-339.
28. Via CS, Sharrow SO, Shearer GM. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol 1987;139:1840-1849.
29. Dvorak HF, Mihm MC, Dvorak AM, et al. Rejection of first-set skin allografts in man. J Exp Med 1979;150:322-337.
30. Dumler JS, Beschorner WE, Farmer ER, et al. Endothelial-cell injury in cutaneous acute graft-versus-host disease. Am J Pathol 1989;135:1097-1103.
31. Biedermann BC, Sahner S, Gregor M, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 2002;359:2078-2083.
32. Ertault-Daneshpouy M, Leboeuf C, Lemann M, et al. Pericapillary hemorrhage as criterion of severe human digestive graft-versus host disease. Blood 2004;103:4681-4684.
33. Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996;88:3230-3239.
34. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
35. Beilhack A, Schulz S, Baker J, et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 2005;106:1113-1122.
36. Krammer P. CD95's deadly mission in the immune system. Nature 2000;407:789-795.
37. Su H, Bidere N, Zheng L, et al. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 2005;307:1465-1468.
38. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365.
39. Godfrey WR, Krampf MR, Taylor PA, et al. Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation. Blood 2004;103:1158-1165.
40. Schneider P, Holler N, Bodmer JL, et al. Conversion of membranebound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998;187:1205-1213.
41. Huang DCS, Hahne M, Schroeter M, et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-XL. Proc Natl Acad Sci USA 1999;96:14871-14876.
42. Monleon I, Martinez-Lorenzo MJ, Monteagudo L, et al. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosisinducing ligand-carrying microvesicles during activation-induced death of human T cells. J Immunol 2001;167:6736-6744.
43. Andreola G, Rivoltini L, Castelli C, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 2002;195:1303-1316.
44. Martinez-Lorenzo MJ, Anel A, Gamen S, et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol 1999;163:1274-1281.
45. Lelièvre JD, Mammano F, Arnoult D, et al. A novel mechanism for HIV1-mediated bystander CD4+ T-cell death: neighbouring dying cells drive the capacity of HIV1 to kill non-cycling primary CD4+ T cells. Cell Death and Differentiation 2004;11:1017-1027.
46. Kagi D, Vignaux F, Ledermann B, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994;265:528-530.
47. Dahllof G, Heimdahl A, Modeer T, et al. Oral mucous membrane lesions in children treated with bone marrow transplantation. Scand J Dent Res 1989;97:268-277.
48. Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992;80:2964-2968.
49. Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001;293:293-297.
50. Birchall MA, Winterford CM, Allan DJ, et al. Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: a preliminary study. Eur J Cancer B Oral Oncol 1995;31B:380-383.
51. Boyd A, Nanney L, Cameron G, et al. Expression of bcl-2 in lichen planus, acute graft-versus-host disease, and erythema multiforme. Am J Dermatopathol 1997;19:46-51.
52. Chrysomali E, Greenspan JS, Dekker N, et al. Apoptosis associated proteins in oral hairy leukoplasia. Oral Dis 1996;2:279-284.
53. Chrysomali E, Lozada-Nur F, Dekker NP, et al. Apoptosis in oral erythema multiforme. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:272-280.
54. Honma T, Saito T, Fujioka Y. Possible role of apoptotic cells of the oral epithelium in the pathogenesis of aphthous ulceration. Oral Surg Oral Med Oral Pathol 1985;59:379-387.
55. Reich K, Brinck U, Letschert M, et al. Graft-versus-host disease like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus. Br J Dermatol 1999;141:739-746.
56. Abe R, Shimizu T, Shibaki A, et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 2003;162:1515-1520.